Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary biliary cirrhosis].

Chae Yoon Chon1, Jun Yong Park

  • 1Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

The Korean Journal of Hepatology
|September 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.

Journal of Korean medical science·2021
Same author

Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma.

Journal of cancer research and clinical oncology·2021
Same author

The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma.

European journal of internal medicine·2021
Same author

Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea.

Journal of gastroenterology and hepatology·2021
Same author

External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals.

Journal of viral hepatitis·2021
Same author

Predictors of Sarcopenia in an Obese Asian Population.

Nutrition and cancer·2021

Primary biliary cirrhosis (PBC) is an autoimmune liver disease affecting middle-aged women. Early diagnosis and ursodeoxycholic acid (UDCA) treatment improve survival and delay disease progression.

Area of Science:

  • Hepatology
  • Autoimmune Diseases
  • Gastroenterology

Background:

  • Primary biliary cirrhosis (PBC) is a chronic, autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts.
  • Pathogenesis involves genetic and environmental factors, with antimitochondrial antibody (AMA) as a key diagnostic marker.
  • PBC predominantly affects middle-aged women, often diagnosed during asymptomatic stages with symptoms like fatigue and pruritus.

Purpose of the Study:

  • To review the current understanding of Primary Biliary Cirrhosis (PBC) pathogenesis, diagnosis, and management.
  • To highlight the importance of early diagnosis and the role of ursodeoxycholic acid (UDCA) in treatment.
  • To discuss liver transplantation as a therapeutic option for end-stage disease.

Main Methods:

Related Experiment Videos

  • Literature review of primary biliary cirrhosis (PBC) studies.
  • Analysis of diagnostic markers, including antimitochondrial antibody (AMA).
  • Evaluation of current and historical treatment strategies for PBC.

Main Results:

  • Antimitochondrial antibody (AMA) is detected in over 90% of PBC patients, but its titer does not correlate with disease severity.
  • Ursodeoxycholic acid (UDCA) is the only approved medical treatment, effectively delaying disease progression and improving survival.
  • Immunosuppressive agents show limited efficacy in altering the natural course of PBC.

Conclusions:

  • Early diagnosis and treatment of PBC, particularly with UDCA, are crucial for improving patient outcomes and survival rates.
  • Liver transplantation remains the definitive option for patients with end-stage liver disease or poor quality of life.
  • Ongoing research into the multifactorial pathogenesis of PBC may lead to novel therapeutic approaches.